Neoadjuvant Therapy for Pancreatic Cancer: Increased Use and Improved Optimal Outcomes.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the American College of Surgeons"
DOI: 10.1097/xcs.0000000000000095
Abstract: BACKGROUND The introduction of more effective chemotherapy a decade ago has led to increased use of neoadjuvant therapy (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC). The aim of this study was to assess the… read more here.
Keywords: neoadjuvant therapy; improved optimal; use nat; increased use ... See more keywords